A Dynamical Framework for the All-or-None G1/S Transition
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The transition from G1 into DNA replication (S phase) is an emergent behavior resulting from dynamic and complex interactions between cyclin-dependent kinases (Cdks), Cdk inhibitors (CKIs), and the anaphase-promoting complex/cyclosome (APC/C). Understanding the cellular decision to commit to S phase requires a quantitative description of these interactions. We apply quantitative imaging of single human cells to track the expression of G1/S regulators and use these data to parametrize a stochastic mathematical model of the G1/S transition. We show that a rapid, proteolytic, double-negative feedback loop between Cdk2:Cyclin and the Cdk inhibitor p27(Kip1) drives a switch-like entry into S phase. Furthermore, our model predicts that increasing Emi1 levels throughout S phase are critical in maintaining irreversibility of the G1/S transition, which we validate using Emi1 knockdown and live imaging of G1/S reporters. This work provides insight into the general design principles of the signaling networks governing the temporally abrupt transitions between cell-cycle phases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
The history and future of targeting cyclin-dependent kinases in cancer therapy
Asghar, U., Witkiewicz, A. K., Turner, N. C., & Knudsen, E. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4504 · Cited by 1,767 · cited 1×
“Moreover, many cancer cells do not have an intact restriction point (Asghar et al., 2015), and thus, inhibition of the G1/S transition is an attractive therapeutic target to stop these cancer cells from proliferating.”
BackgroundScaltriti, M., Eichhorn, P. J., Cortés, J., Prudkin, L., Aura, C., Jiménez, J., Chandarlapaty, S., Serra, V., Prat, A., Ibrahim, Y. H., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014835108 · Cited by 337 · cited 2×
“or the All-or-None G1/S”
Background
Research works printed but not linked: 68
- Bashir, 2004, Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase, Nature, 428, 190, 10.1038/nature02330 · DOI · Paper page
- Bertoli, 2013, Control of cell cycle transcription during G1 and S phases, Nat. Rev. Mol. Cell Biol., 14, 518, 10.1038/nrm3629 · DOI · Paper page
- Boshart, 1984, A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer, EMBO J., 3, 1151, 10.1002/j.1460-2075.1984.tb01944.x · DOI · Paper page
- Butz, 1995, Functional p53 protein in human papillomavirus-positive cancer cells, Oncogene, 10, 927
- Carrano, 1999, SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27, Nat. Cell Biol., 1, 193, 10.1038/12013 · DOI · Paper page
- Charvin, 2010, Origin of irreversibility of cell cycle start in budding yeast, PLoS Biol., 8, e1000284, 10.1371/journal.pbio.1000284 · DOI
- Chen, 2000, Kinetic analysis of a molecular model of the budding yeast cell cycle, Mol. Biol. Cell, 11, 369, 10.1091/mbc.11.1.369 · DOI · Paper page
- Chu, 2008, The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy, Nat. Rev. Cancer, 8, 253, 10.1038/nrc2347 · DOI · Paper page
- Ciotta, 2011, Recombineering BAC transgenes for protein tagging, Methods, 53, 113, 10.1016/j.ymeth.2010.09.003 · DOI
- Cross, 2002, Testing a mathematical model of the yeast cell cycle, Mol. Biol. Cell, 13, 52, 10.1091/mbc.01-05-0265 · DOI · Paper page
- Cross, 2011, Evolution of networks and sequences in eukaryotic cell cycle control, Philos. Trans. R. Soc. Lond. B Biol. Sci., 366, 3532, 10.1098/rstb.2011.0078 · DOI
- den Elzen, 2001, Cyclin A is destroyed in prometaphase and can delay chromosome alignment and anaphase, J. Cell Biol., 153, 121, 10.1083/jcb.153.1.121 · DOI · Paper page
- Di Fiore, 2007, Emi1 is needed to couple DNA replication with mitosis but does not regulate activation of the mitotic APC/C, J. Cell Biol., 177, 425, 10.1083/jcb.200611166 · DOI
- Dulić, 1992, Association of human cyclin E with a periodic G1-S phase protein kinase, Science, 257, 1958, 10.1126/science.1329201 · DOI · Paper page
- Dürst, 1987, Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas, Proc. Natl. Acad. Sci. USA, 84, 1070, 10.1073/pnas.84.4.1070 · DOI · Paper page
- Essers, 2005, Nuclear dynamics of PCNA in DNA replication and repair, Mol. Cell. Biol., 25, 9350, 10.1128/MCB.25.21.9350-9359.2005 · DOI · Paper page
- Fero, 1996, A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice, Cell, 85, 733, 10.1016/S0092-8674(00)81239-8 · DOI · Paper page
- Geley, 2001, Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint, J. Cell Biol., 153, 137, 10.1083/jcb.153.1.137 · DOI · Paper page
- Geng, 1996, Regulation of cyclin E transcription by E2Fs and retinoblastoma protein, Oncogene, 12, 1173
- Geng, 2003, Cyclin E ablation in the mouse, Cell, 114, 431, 10.1016/S0092-8674(03)00645-7 · DOI · Paper page
- Gu, 2004, Cell cycle-dependent regulation of a human DNA helicase that localizes in DNA damage foci, Mol. Biol. Cell, 15, 3320, 10.1091/mbc.E04-03-0227 · DOI
- Held, 2010, CellCognition: time-resolved phenotype annotation in high-throughput live cell imaging, Nat. Methods, 7, 747, 10.1038/nmeth.1486 · DOI · Paper page
- Hershko, 2010, Cyclin-dependent kinase inhibitor p27 as a prognostic biomarker and potential cancer therapeutic target, Future Oncol., 6, 1837, 10.2217/fon.10.144 · DOI
- Hsu, 2002, E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC(Cdh1), Nat. Cell Biol., 4, 358, 10.1038/ncb785 · DOI · Paper page
- Hutchins, 2010, Systematic analysis of human protein complexes identifies chromosome segregation proteins, Science, 328, 593, 10.1126/science.1181348 · DOI · Paper page
- Johnson, 2013, Start and the restriction point, Curr. Opin. Cell Biol., 25, 717, 10.1016/j.ceb.2013.07.010 · DOI · Paper page
- Keck, 2007, Cyclin E overexpression impairs progression through mitosis by inhibiting APC(Cdh1), J. Cell Biol., 178, 371, 10.1083/jcb.200703202 · DOI
- Kiyokawa, 1996, Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1), Cell, 85, 721, 10.1016/S0092-8674(00)81238-6 · DOI · Paper page
- Koff, 1992, Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle, Science, 257, 1689, 10.1126/science.1388288 · DOI · Paper page
- Kohn, 1999, Molecular interaction map of the mammalian cell cycle control and DNA repair systems, Mol. Biol. Cell, 10, 2703, 10.1091/mbc.10.8.2703 · DOI · Paper page
- Kõivomägi, 2011, Cascades of multisite phosphorylation control Sic1 destruction at the onset of S phase, Nature, 480, 128, 10.1038/nature10560 · DOI · Paper page
- Lazo, 1989, Amplification of the integrated viral transforming genes of human papillomavirus 18 and its 5′-flanking cellular sequence located near the myc protooncogene in HeLa cells, Cancer Res., 49, 4305
- Leonhardt, 2000, Dynamics of DNA replication factories in living cells, J. Cell Biol., 149, 271, 10.1083/jcb.149.2.271 · DOI · Paper page
- Lukas, 1999, Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex, Nature, 401, 815, 10.1038/44611 · DOI · Paper page
- Machida, 2007, The APC/C inhibitor, Emi1, is essential for prevention of rereplication, Genes Dev., 21, 184, 10.1101/gad.1495007 · DOI · Paper page
- Martín, 2005, Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1), Cancer Cell, 7, 591, 10.1016/j.ccr.2005.05.006 · DOI · Paper page
- Miller, 2006, Emi1 stably binds and inhibits the anaphase-promoting complex/cyclosome as a pseudosubstrate inhibitor, Genes Dev., 20, 2410, 10.1101/gad.1454006 · DOI · Paper page
- Montagnoli, 1999, Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation, Genes Dev., 13, 1181, 10.1101/gad.13.9.1181 · DOI · Paper page
- Moody, 2010, Human papillomavirus oncoproteins: pathways to transformation, Nat. Rev. Cancer, 10, 550, 10.1038/nrc2886 · DOI · Paper page
- Morgan, 1997, Cyclin-dependent kinases: engines, clocks, and microprocessors, Annu. Rev. Cell Dev. Biol., 13, 261, 10.1146/annurev.cellbio.13.1.261 · DOI · Paper page
- Müller, 1997, Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes, Oncogene, 15, 2561, 10.1038/sj.onc.1201440 · DOI · Paper page
- Nakayama, 1996, Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors, Cell, 85, 707, 10.1016/S0092-8674(00)81237-4 · DOI · Paper page
- Nash, 2001, Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication, Nature, 414, 514, 10.1038/35107009 · DOI · Paper page
- Neelsen, 2013, Deregulated origin licensing leads to chromosomal breaks by rereplication of a gapped DNA template, Genes Dev., 27, 2537, 10.1101/gad.226373.113 · DOI · Paper page
- Ohtani, 1995, Regulation of the cyclin E gene by transcription factor E2F1, Proc. Natl. Acad. Sci. USA, 92, 12146, 10.1073/pnas.92.26.12146 · DOI · Paper page
- Overton, 2014, Basal p21 controls population heterogeneity in cycling and quiescent cell cycle states, Proc. Natl. Acad. Sci. USA, 111, E4386, 10.1073/pnas.1409797111 · DOI · Paper page
- Piatkevich, 2010, Monomeric red fluorescent proteins with a large Stokes shift, Proc. Natl. Acad. Sci. USA, 107, 5369, 10.1073/pnas.0914365107 · DOI · Paper page
- Pines, 1990, Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B, Nature, 346, 760, 10.1038/346760a0 · DOI · Paper page
- Pomerening, 2008, Rapid cycling and precocious termination of G1 phase in cells expressing CDK1AF, Mol. Biol. Cell, 19, 3426, 10.1091/mbc.E08-02-0172 · DOI
- Poser, 2008, BAC TransgeneOmics: a high-throughput method for exploration of protein function in mammals, Nat. Methods, 5, 409, 10.1038/nmeth.1199 · DOI · Paper page
- Sabile, 2006, Regulation of p27 degradation and S-phase progression by Ro52 RING finger protein, Mol. Cell. Biol., 26, 5994, 10.1128/MCB.01630-05 · DOI
- Schwarz, 1985, Structure and transcription of human papillomavirus sequences in cervical carcinoma cells, Nature, 314, 111, 10.1038/314111a0 · DOI · Paper page
- Schwob, 1994, The B-type cyclin kinase inhibitor p40SIC1 controls the G1 to S transition in S. cerevisiae, Cell, 79, 233, 10.1016/0092-8674(94)90193-7 · DOI · Paper page
- Sheaff, 1997, Cyclin E-CDK2 is a regulator of p27Kip1, Genes Dev., 11, 1464, 10.1101/gad.11.11.1464 · DOI · Paper page
- Skotheim, 2008, Positive feedback of G1 cyclins ensures coherent cell cycle entry, Nature, 454, 291, 10.1038/nature07118 · DOI · Paper page
- Sørensen, 2001, A conserved cyclin-binding domain determines functional interplay between anaphase-promoting complex-Cdh1 and cyclin A-Cdk2 during cell cycle progression, Mol. Cell. Biol., 21, 3692, 10.1128/MCB.21.11.3692-3703.2001 · DOI · Paper page
- Spencer, 2013, The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit, Cell, 155, 369, 10.1016/j.cell.2013.08.062 · DOI · Paper page
- Tetsu, 2003, Proliferation of cancer cells despite CDK2 inhibition, Cancer Cell, 3, 233, 10.1016/S1535-6108(03)00053-9 · DOI · Paper page
- van den Heuvel, 1993, Distinct roles for cyclin-dependent kinases in cell cycle control, Science, 262, 2050, 10.1126/science.8266103 · DOI · Paper page
- Verdugo, 2013, Molecular mechanisms creating bistable switches at cell cycle transitions, Open Biol., 3, 120179, 10.1098/rsob.120179 · DOI
- Vlach, 1997, Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27, EMBO J., 16, 5334, 10.1093/emboj/16.17.5334 · DOI · Paper page
- Wei, 2004, Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex, Nature, 428, 194, 10.1038/nature02381 · DOI · Paper page
- Won, 1996, Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E, EMBO J., 15, 4182, 10.1002/j.1460-2075.1996.tb00793.x · DOI · Paper page
- Yang, 2013, Design principles of the yeast G1/S switch, PLoS Biol., 11, e1001673, 10.1371/journal.pbio.1001673 · DOI
- Yao, 2008, A bistable Rb-E2F switch underlies the restriction point, Nat. Cell Biol., 10, 476, 10.1038/ncb1711 · DOI · Paper page
- Yuan, 2014, Uncovering the role of APC-Cdh1 in generating the dynamics of S-phase onset, Mol. Biol. Cell, 25, 441, 10.1091/mbc.E13-08-0480 · DOI
- Zachariae, 1998, Control of cyclin ubiquitination by CDK-regulated binding of Hct1 to the anaphase promoting complex, Science, 282, 1721, 10.1126/science.282.5394.1721 · DOI · Paper page
- Zetterberg, 1995, What is the restriction point?, Curr. Opin. Cell Biol., 7, 835, 10.1016/0955-0674(95)80067-0 · DOI · Paper page
Cited by
Matthews, H. K., Bertoli, C., & de Bruin, R. A. M. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00404-3 · Cited by 1,506
Barr, A. R., Cooper, S., Heldt, F. S., Butera, F., Stoy, H., Mansfeld, J., Novák, B., & Bakal, C. (2017) · Nature Communications · doi:10.1038/ncomms14728 · Cited by 403
Self-citationSingle-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast Cancer
Asghar, U. S., Barr, A. R., Cutts, R., Beaney, M., Babina, I., Sampath, D., Giltnane, J., Lacap, J. A., Crocker, L., Young, A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0369 · Cited by 268
Self-citationIntegrating Old and New Paradigms of G1/S Control
Rubin, S. M., Sage, J., & Skotheim, J. M. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.08.020 · Cited by 264
Myoglianin triggers the premetamorphosis stage in hemimetabolan insects
Kamsoi, O., & Belles, X. (2019) · The FASEB Journal · doi:10.1096/fj.201801511r · Cited by 49
(2022) · doi:10.1021/acssynbio.2c00347 · Cited by 4
Metadata
- Authors
- Barr, A. R., Heldt, F. S., Zhang, T., Bakal, C., & Novák, B.
- Venue
- Cell Systems
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 2
- Issue
- 1
- Pages
- 27-37
- ISSN
- 2405-4712 (ISSN-L)
- OpenAlex
- W2250544263
- Cited by
- 125
- References
- 5
- FWCI
- 7.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.